Počet záznamov: 1
tadalafil
SYS d000068581 LBL 00000cz--a2200181n--4500 005 20250606221736.8 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $a BA006 $a BA006 $d BA006 065 $a D03.383.725.150.500 065 $a D03.633.100.473.402.111.500 065 $a D03.633.300.154.672 066 $a 01 $c 03 150 $a tadalafil $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)- $2 eng 450 $w v $a IC 351 $2 slo 450 $w v $a pyrazín(1',2':1,6)pyrido(3,4-b)indol-1,4-dión, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-metyl-, (6R,12aR)- $2 slo 450 $w v $a IC 351 $2 slo 450 $w v $a Cialis $2 slo 550 $7 sllk_us_auth*d014665 $Y Vasodilator Agents $w P $a látky vazodilatačné 550 $7 sllk_us_auth*d058986 $Y Phosphodiesterase 5 Inhibitors $w P $a inhibítory fosfodiesterázy 5 550 $7 sllk_us_auth*d064804 $Y Urological Agents $w P $a urologiká 550 $7 sllk_us_auth*d000068677 $Y Sildenafil Citrate $w p $a sildenafil citrát 550 $7 sllk_us_auth*d000068677 $Y Sildenafil Citrate $w b $a sildenafil citrát 665 $a 2016 (2001) $2 eng 680 9-
$i A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION. $2 eng 750 -2
$a Tadalafil $2 eng 980 $x M
Počet záznamov: 1